Mode
Text Size
Log in / Sign up

Cerebral Palsy

Part of Encephalopathy

18 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Cerebral Palsy

75 trials tracked for Cerebral Palsy: 12 in phase 3 or 4 and 2 with published results. The most-cited published study has 42 citations.

75Trials tracked
12Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 10 Phase 2 6 Phase 1 6 Other / NA 51
  1. Phase 3 Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability Completed · 42 cited
  2. Phase 3 Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy Completed · 19 cited
  3. Phase 4 A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging Completed
  4. Phase 4 Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy Completed
  5. Phase 3 Dysport® Pediatric Lower Limb Spasticity Study Completed
  6. Phase 3 Dysport® Pediatric Lower Limb Spasticity Follow-on Study Completed
Show 44 more trials
  1. Phase 3 BOTOX® Treatment in Pediatric Lower Limb Spasticity Completed
  2. Phase 3 BOTOX® Treatment in Pediatric Upper Limb Spasticity Completed
  3. Phase 3 BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity Completed
  4. Phase 3 BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity Completed
  5. Phase 3 Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy Completed
  6. Phase 3 Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions Completed
  7. Phase 2 Endermotherapy for Children With Developmental Disabilities Completed
  8. Phase 2 Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP). Completed
  9. Phase 2 Effect of Power Wheelchairs on the Development and Function of Young Children With Severe Physical Disabilities Completed
  10. Phase 2 A Study of UCB and MSCs in Children With CP: ACCeNT-CP Completed
  11. Phase 2 P300 Brain Computer Interface Keyboard to Operate Assistive Technology Completed
  12. Phase 2 A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy Completed
  13. Phase 1 Telehealth Virtual Reality Gaming on Cardiometabolic Health Among Youth With Cerebral Palsy Completed
  14. Phase 1 Development of a Robotic Ankle Assist Device Completed
  15. Phase 1 Testing an Adjustable Ankle Orthosis During Walking in Cerebral Palsy Completed
  16. Phase 1 Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Completed
  17. Phase 1 Evaluating Wearable Robotic Assistance on Gait Completed
  18. Phase 1 Extending taVNS Paired With Infant CIMT Into a Home-Based Setting Completed
  19. N/A Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP Completed
  20. N/A Early Powered Mobility for Toddlers With Cerebral Palsy Using the Permobil® Explorer Mini and a Modified Ride-On Car Completed
  21. N/A Study Assessing High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations Completed
  22. N/A Evaluation of Project TEAM (Teens Making Environmental and Activity Modifications) Completed
  23. N/A Intelligent and Adaptive Control Applied to Powered Walkers Completed
  24. N/A Physical and Social Benefits of Multi-Player Interactive Computer Play Games in Youth With Cerebral Palsy Completed
  25. N/A Constraint-induced Movement Therapy (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegic Cerebral Palsy Completed
  26. N/A A Pilot Study of Hand Function in Children With Cerebral Palsy Undergoing Intensive Neurophysiological Rehabilitation Completed
  27. N/A Clinical Utility of Pediatric Whole Exome Sequencing Completed
  28. N/A Cerebral Palsy Early Mobility Training Completed
  29. N/A SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants Completed
  30. N/A Orthotics in Ambulatory Cerebral Palsy Completed
  31. N/A Intensive Unimanual (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegia Completed
  32. N/A Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy Completed
  33. N/A Effects of Hippotherapy on Physical Fitness and Attention in Cerebral Palsy Completed
  34. N/A Managing Post-operative Pain in Children With Cerebral Palsy Using a Pain Pump Completed
  35. N/A Precision Gait Retraining for Children With Cerebral Palsy Completed
  36. N/A Therapeutic Dance Intervention for Children With Cerebral Palsy Completed
  37. N/A Effect of Trunk Stabilization Exercises on Quality of Life and Communication in Cerebral Palsy Completed
  38. N/A Seating System for Scoliosis in Non-ambulatory Children With Cerebral Palsy: A Pilot Randomized Controlled Trial Completed
  39. N/A Dynamic Gait Index in Hemiplegic Cerebral Palsy Completed
  40. N/A The TOBY Children Study Completed
  41. N/A Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy Completed
  42. N/A A Study of Neurophysiologically Based Occupational Therapy Intervention (NBOTI) for Feeding in the NCCU. Completed
  43. N/A Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy Completed
  44. N/A NEO Rehab Program for Premature Infants at Risk for Cerebral Palsy Completed

Showing the 50 most-cited and recently-updated of 75 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Cerebral Palsy: what the trials found

Botulinum toxin type A (including incobotulinumtoxinA, NT 201, Dysport) is established for reducing spasticity in cerebral palsy. In lower limb, botulinum toxin type A significantly improved Modified Ashworth Scale (MAS) scores in the gastrocnemius-soleus complex at the ankle (p=0.0029) 15 and ankle score with knee extended (p=0.010) 13, with corresponding improvements in Physician's Global Assessment (p<0.0001) 15 and Clinical Global Impression (p=0.023) 13. In upper limb, incobotulinumtoxinA 8 U/kg significantly improved Ashworth Scale in the primary clinical target pattern at week 4 (p=0.017) 8, and botulinum toxin type A significantly improved mean MAS score for all injected upper limb muscle groups 14. However, some secondary outcomes like Investigator's GICS (p=0.34) 8 and CGI (p=0.155) 12 did not reach significance, indicating mixed evidence on global impression measures.

For sialorrhea (drooling) in cerebral palsy, NT 201 (botulinum toxin type A) significantly reduced unstimulated salivary flow rate at week 4 (p=0.0012) and weeks 8 and 12 (p<0.0001) compared to placebo, and improved Global Impression of Change Scale as assessed by carer/parent at week 4 (p=0.032) 7. Oral glycopyrrolate liquid is also established for this indication 16.

For post-operative pain, ropivacaine injection showed lower pain scores (1.0 vs 2.4) compared to control 5. Dexmedetomidine bolus with high infusion and propofol has been studied 6.

Adverse events: In phase 3 trials, botulinum toxin type A was associated with treatment-emergent adverse events in 58.7% 10 and 65.4% 11 of participants.

Recent results — preliminary, needs further review

  • Sprint-intensity interval training with telecoaching showed changes in lean tissue percentage (0.81 vs -0.21) and fat tissue percentage (-0.23 vs 1.72) in a phase 1 trial 1.
  • Sensorimotor intervention was investigated in a small phase N/A trial (N=11) 2.
  • Therapeutic dance was explored in a phase N/A trial (N=9) 3.
  • Varying levels of harness support during walking were studied in a phase N/A trial (N=34) 4.

For the clinician treating this condition

  • Botulinum toxin type A is effective for focal spasticity in both upper and lower limbs, with consistent improvements on objective scales like MAS, though global impression measures may not always reach significance.
  • NT 201 is effective for sialorrhea, reducing salivary flow and improving carer/parent-rated global impression.
  • Ropivacaine injection can reduce post-operative pain scores.
  • Recent small trials on sprint-interval training, sensorimotor intervention, therapeutic dance, and harness support are preliminary and require further confirmation.

AI synthesis of 15 cited trials, updated Jun 27, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Encephalopathy

Related studies from across the Encephalopathy family.

Questions about Cerebral Palsy

How do prenatal and neonatal factors affect the risk of cerebral periventricular leukomalacia in preterm infants?

Prenatal infections, low gestational age, and neonatal factors like low cerebral blood flow and oxygen levels increase the risk of cystic periventricular leukomalacia (cPVL) in preterm infants, which can lead to cerebral palsy.

Full answer →
Which surgical or neuromodulation options are best for functional outcomes in ambulatory children with cerebral palsy?

For ambulatory children with cerebral palsy, selective dorsal rhizotomy (SDR) is often considered best for spastic diplegia, while deep brain stimulation (DBS) helps dystonia; intrathecal baclofen (ITB) and peripheral neurectomies are other options. Choice depends on individual s

Full answer →
What genetic factors are linked to the specific characteristics of cerebral palsy in children?

Genetic factors are linked to cerebral palsy characteristics, with 12.2% of patients in a large US registry having a genetic etiology, and genetic causes are associated with specific motor function levels and movement types.

Full answer →

All Cerebral Palsy Articles